ID

13236

Descrição

A Safety Study of SGN-CD33A in AML Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01902329

Link

https://clinicaltrials.gov/show/NCT01902329

Palavras-chave

  1. 25/01/2016 25/01/2016 -
Titular dos direitos

CC BY-NC 3.0

Transferido a

25 de janeiro de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Acute Myelogenous Leukemia NCT01902329

Eligibility Acute Myelogenous Leukemia NCT01902329

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
acute myeloid leukemia, positive for cd33
Descrição

AML

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023467
eastern cooperative oncology group status of 0 or 1
Descrição

ECOG

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
adequate baseline renal and hepatic function
Descrição

renal and hepatic function

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0232804
UMLS CUI [1,2]
C0232741
central venous access
Descrição

central venous access

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1145640
either achieved complete remission (greater than 12 weeks in duration) with initial induction/consolidation and have experienced relapse of disease or declined treatment with high-dose induction/consolidation
Descrição

remission or relapse

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0544452
UMLS CUI [2]
C0277556
bone marrow blasts greater than or equal to 5% for relapsed patients, or greater than or equal to 20% for untreated patients
Descrição

bone marrow blasts

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0368761
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
inadequate lung function
Descrição

pulmonary function

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0231921
prior allogeneic stem cell transplant, except for a specific cohort
Descrição

stem cell transplant

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1504389
high-dose chemotherapy within 4 weeks of study drug
Descrição

chemotherapy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0392920
antileukemia treatment within 14 days of study drug (other than hydroxyurea or 6-mercaptopurine)
Descrição

antileukemia treatment

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0087111

Similar models

Eligibility Acute Myelogenous Leukemia NCT01902329

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
AML
Item
acute myeloid leukemia, positive for cd33
boolean
C0023467 (UMLS CUI [1])
ECOG
Item
eastern cooperative oncology group status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
renal and hepatic function
Item
adequate baseline renal and hepatic function
boolean
C0232804 (UMLS CUI [1,1])
C0232741 (UMLS CUI [1,2])
central venous access
Item
central venous access
boolean
C1145640 (UMLS CUI [1])
remission or relapse
Item
either achieved complete remission (greater than 12 weeks in duration) with initial induction/consolidation and have experienced relapse of disease or declined treatment with high-dose induction/consolidation
boolean
C0544452 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
bone marrow blasts
Item
bone marrow blasts greater than or equal to 5% for relapsed patients, or greater than or equal to 20% for untreated patients
boolean
C0368761 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pulmonary function
Item
inadequate lung function
boolean
C0231921 (UMLS CUI [1])
stem cell transplant
Item
prior allogeneic stem cell transplant, except for a specific cohort
boolean
C1504389 (UMLS CUI [1])
chemotherapy
Item
high-dose chemotherapy within 4 weeks of study drug
boolean
C0392920 (UMLS CUI [1])
antileukemia treatment
Item
antileukemia treatment within 14 days of study drug (other than hydroxyurea or 6-mercaptopurine)
boolean
C0087111 (UMLS CUI [1])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial